Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Crystal structures of the human neurokinin 1 receptor in complex with clinically used antagonists
Jendrik Schöppe, Janosch Ehrenmann, Christoph Klenk, et al.
Nature Communications (2018) Vol. 10, Iss. 1
Open Access | Times Cited: 91

Showing 1-25 of 91 citing articles:

Structure-based design of bitopic ligands for the µ-opioid receptor
Abdelfattah Faouzi, Haoqing Wang, Saheem A. Zaidi, et al.
Nature (2022) Vol. 613, Iss. 7945, pp. 767-774
Closed Access | Times Cited: 82
Determination of the melanocortin-4 receptor structure identifies Ca 2+ as a cofactor for ligand binding
Jing Yu, Luis E. Gimenez, Ciria C. Hernández, et al.
Science (2020) Vol. 368, Iss. 6489, pp. 428-433
Open Access | Times Cited: 115
Harnessing Ion-Binding Sites for GPCR Pharmacology
Barbara Zarzycka, Saheem A. Zaidi, Bryan L. Roth, et al.
Pharmacological Reviews (2019) Vol. 71, Iss. 4, pp. 571-595
Open Access | Times Cited: 109
Crystal structure of the human oxytocin receptor
Yann Waltenspühl, Jendrik Schöppe, Janosch Ehrenmann, et al.
Science Advances (2020) Vol. 6, Iss. 29
Open Access | Times Cited: 86
The Neurokinin-1 Receptor Antagonist Aprepitant: An Intelligent Bullet against Cancer?
Miguel Muñoz, Rafael Coveñas
Cancers (2020) Vol. 12, Iss. 9, pp. 2682-2682
Open Access | Times Cited: 81
Selective G protein signaling driven by substance P–neurokinin receptor dynamics
J.A. Harris, Bryan Faust, Arisbel B. Gondin, et al.
Nature Chemical Biology (2021) Vol. 18, Iss. 1, pp. 109-115
Open Access | Times Cited: 70
Occurrence of Morpholine in Central Nervous System Drug Discovery
Elena Lenci, Lorenzo Calugi, Andrea Trabocchi
ACS Chemical Neuroscience (2021) Vol. 12, Iss. 3, pp. 378-390
Open Access | Times Cited: 57
Structures of neurokinin 1 receptor in complex with G q and G s proteins reveal substance P binding mode and unique activation features
Cristian Thom, Janosch Ehrenmann, Santiago Vacca, et al.
Science Advances (2021) Vol. 7, Iss. 50
Open Access | Times Cited: 42
Therapeutic antagonism of the neurokinin 1 receptor in endosomes provides sustained pain relief
Alan Hégron, Chloe J. Peach, Raquel Tonello, et al.
Proceedings of the National Academy of Sciences (2023) Vol. 120, Iss. 22
Open Access | Times Cited: 19
Sustained endosomal release of a neurokinin-1 receptor antagonist from nanostars provides long-lasting relief of chronic pain
Rocco Latorre, Paulina D. Ramírez-García, Alan Hégron, et al.
Biomaterials (2022) Vol. 285, pp. 121536-121536
Open Access | Times Cited: 26
GPCR large-amplitude dynamics by 19 F-NMR of aprepitant bound to the neurokinin 1 receptor
Benxun Pan, Dongsheng Liu, Lingyun Yang, et al.
Proceedings of the National Academy of Sciences (2022) Vol. 119, Iss. 15
Open Access | Times Cited: 23
Occurrence of “Natural Selection” in Successful Small Molecule Drug Discovery
Anna Lina Heinzke, Axel Pahl, Barbara Zdrazil, et al.
Journal of Medicinal Chemistry (2024) Vol. 67, Iss. 13, pp. 11226-11241
Open Access | Times Cited: 5
Substance P and neurokinin 1 receptor boost the pathogenicity of granulocyte‐macrophage colony‐stimulating factor‐producing T helper cells in dry eye disease
Rong Hua, Yang Hai, Qingqing Liu, et al.
Scandinavian Journal of Immunology (2025) Vol. 101, Iss. 1
Closed Access
Structure-guided design of partial agonists at an opioid receptor
Balázs R. Varga, Sarah M. Bernhard, Amal El Daibani, et al.
Nature Communications (2025) Vol. 16, Iss. 1
Open Access
Cryo-EM as a tool for illuminating activation mechanisms of human class A orphan GPCRs
Isabella C. Russell, Dongju Lee, Denise Wootten, et al.
Pharmacological Reviews (2025), pp. 100056-100056
Open Access
Proton perception and activation of a proton-sensing GPCR
Li-Nan Chen, Hui Zhou, Kun Xi, et al.
Molecular Cell (2025)
Closed Access
Peptidergic Systems and Cancer: Focus on Tachykinin and Calcitonin/Calcitonin Gene-Related Peptide Families
Manuel Lisardo Sánchez, Francisco D. Rodríguez, Rafael Coveñas
Cancers (2023) Vol. 15, Iss. 6, pp. 1694-1694
Open Access | Times Cited: 11
Signaling Modulation Mediated by Ligand Water Interactions with the Sodium Site at μOR
Rohini S. Ople, Nokomis Ramos‐Gonzalez, Qiongyu Li, et al.
ACS Central Science (2024) Vol. 10, Iss. 8, pp. 1490-1503
Open Access | Times Cited: 4
MultiBac: Baculovirus-Mediated Multigene DNA Cargo Delivery in Insect and Mammalian Cells
Kapil Gupta, Christine Tölzer, Duygu Sari, et al.
Viruses (2019) Vol. 11, Iss. 3, pp. 198-198
Open Access | Times Cited: 34
Understanding Peptide Binding in Class A G Protein-Coupled Receptors
Irina G. Tikhonova, Véronique Gigoux, Daniel Fourmy
Molecular Pharmacology (2019) Vol. 96, Iss. 5, pp. 550-561
Open Access | Times Cited: 31
Novel NK1R-Targeted 68Ga-/177Lu-Radioconjugates with Potential Application against Glioblastoma Multiforme: Preliminary Exploration of Structure–Activity Relationships
Joanna Matalińska, Katarzyna Kosińska, Paweł Krzysztof Halik, et al.
International Journal of Molecular Sciences (2022) Vol. 23, Iss. 3, pp. 1214-1214
Open Access | Times Cited: 16
Production of membrane proteins in industry: The example of GPCRs
James C. Errey, Cédric Fiez-Vandal
Protein Expression and Purification (2020) Vol. 169, pp. 105569-105569
Closed Access | Times Cited: 26
In silico screening of neurokinin receptor antagonists as a therapeutic strategy for neuroinflammation in Alzheimer’s disease
Sairaj Satarker, Swastika Maity, Jayesh Mudgal, et al.
Molecular Diversity (2021) Vol. 26, Iss. 1, pp. 443-466
Open Access | Times Cited: 21
The Repurposing of Non-Peptide Neurokinin-1 Receptor Antagonists as Antitumor Drugs: An Urgent Challenge for Aprepitant
Rafael Coveñas, Francisco D. Rodríguez, Prema Robinson, et al.
International Journal of Molecular Sciences (2023) Vol. 24, Iss. 21, pp. 15936-15936
Open Access | Times Cited: 8
Mechanism of negative μ-opioid receptor modulation by sodium ions
Neil J. Thomson, Ulrich Zachariae
Structure (2024)
Open Access | Times Cited: 2
Page 1 - Next Page

Scroll to top